BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23633236)

  • 21. Performance of fluorescence in situ hybridization in biliary brushings with equivocal cytology: an institutional experience.
    Miller LJ; Holmes IM; Chen-Yost HI; Smola B; Lew M; Betz BL; Brown NA; Pang J
    J Am Soc Cytopathol; 2024; 13(4):285-290. PubMed ID: 38589274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatography.
    Kipp BR; Fritcher EG; Clayton AC; Gores GJ; Roberts LR; Zhang J; Levy MJ; Halling KC
    J Mol Diagn; 2010 Nov; 12(6):780-6. PubMed ID: 20864634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescence in situ hybridization compared with conventional cytology for the diagnosis of malignant biliary tract strictures in Asian patients.
    Chaiteerakij R; Barr Fritcher EG; Angsuwatcharakon P; Ridtitid W; Chaithongrat S; Leerapun A; Baron TH; Kipp BR; Henry MR; Halling KC; Rerknimitr R; Roberts LR
    Gastrointest Endosc; 2016 Jun; 83(6):1228-35. PubMed ID: 26684604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EUS-FNA with rescue fluorescence in situ hybridization for the diagnosis of pancreatic carcinoma in patients with inconclusive on-site cytopathology results.
    Kubiliun N; Ribeiro A; Fan YS; Rocha-Lima CM; Sleeman D; Merchan J; Barkin J; Levi J
    Gastrointest Endosc; 2011 Sep; 74(3):541-7. PubMed ID: 21752364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorescence in situ hybridisation in the cytological diagnosis of pancreatobiliary tumours.
    Boldorini R; Paganotti A; Sartori M; Allegrini S; Miglio U; Orsello M; Veggiani C; Del Piano M; Monga G
    Pathology; 2011 Jun; 43(4):335-9. PubMed ID: 21519286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refined pancreatobiliary UroVysion criteria and an approach for further optimization.
    Mettman D; Saeed A; Shold J; Laury R; Ly A; Khan I; Golem S; Olyaee M; O'Neil M
    Cancer Med; 2021 Sep; 10(17):5725-5738. PubMed ID: 34374212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlating routine cytology, quantitative nuclear morphometry by digital image analysis, and genetic alterations by fluorescence in situ hybridization to assess the sensitivity of cytology for detecting pancreatobiliary tract malignancy.
    Barr Fritcher EG; Kipp BR; Slezak JM; Moreno-Luna LE; Gores GJ; Levy MJ; Roberts LR; Halling KC; Sebo TJ
    Am J Clin Pathol; 2007 Aug; 128(2):272-9. PubMed ID: 17638662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multistep cytological approach for patients with jaundice and biliary strictures of indeterminate origin.
    Boldorini R; Paganotti A; Andorno S; Orlando S; Mercalli F; Orsello M; Ballarè M; Magnani C; Sartori M
    J Clin Pathol; 2015 Apr; 68(4):283-7. PubMed ID: 25681513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures.
    Levy MJ; Baron TH; Clayton AC; Enders FB; Gostout CJ; Halling KC; Kipp BR; Petersen BT; Roberts LR; Rumalla A; Sebo TJ; Topazian MD; Wiersema MJ; Gores GJ
    Am J Gastroenterol; 2008 May; 103(5):1263-73. PubMed ID: 18477350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis.
    Eaton JE; Barr Fritcher EG; Gores GJ; Atkinson EJ; Tabibian JH; Topazian MD; Gossard AA; Halling KC; Kipp BR; Lazaridis KN
    Am J Gastroenterol; 2015 Feb; 110(2):299-309. PubMed ID: 25623660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
    Njei B; McCarty TR; Varadarajulu S; Navaneethan U
    Gastrointest Endosc; 2017 Apr; 85(4):773-781.e10. PubMed ID: 27590963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures.
    Fritcher EG; Kipp BR; Halling KC; Oberg TN; Bryant SC; Tarrell RF; Gores GJ; Levy MJ; Clayton AC; Sebo TJ; Roberts LR
    Gastroenterology; 2009 Jun; 136(7):2180-6. PubMed ID: 19232347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recall processes for biliary cytology in primary sclerosing cholangitis.
    Eaton JE; Gossard AA; Talwalkar JA
    Curr Opin Gastroenterol; 2014 May; 30(3):287-94. PubMed ID: 24686433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic pitfalls and the value of fluorescence in situ hybridization as an adjunct to cytologic evaluation of bile duct brushings in patients with primary sclerosing cholangitis.
    Selvaggi SM
    Diagn Cytopathol; 2023 Feb; 51(2):117-122. PubMed ID: 36181472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced cytologic approaches for the diagnosis of pancreatobiliary cancer.
    Fritcher EG; Halling KC
    Curr Opin Gastroenterol; 2010 May; 26(3):259-64. PubMed ID: 20393279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An assessment of chromosomal alterations detected by fluorescence in situ hybridisation in pancreatobiliary tract malignancy.
    Pu X; Zheng H; Yang X; Ye Q; Fan Z; Yang J; Fan X; Zhou X; Qiu Y; Huang Q; Wu H; Chen J
    BMC Gastroenterol; 2020 Nov; 20(1):367. PubMed ID: 33148183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunocytochemistry for Claudin-18 and Maspin in biliary brushing cytology increases the accuracy of diagnosing pancreatobiliary malignancies.
    Tokumitsu T; Sato Y; Yamashita A; Moriguchi-Goto S; Kondo K; Nanashima A; Asada Y
    Cytopathology; 2017 Apr; 28(2):116-121. PubMed ID: 27527114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biliary brush cytology and the detection of cholangiocarcinoma in primary sclerosing cholangitis: evaluation of specific cytomorphologic features and CA19-9 levels.
    Furmanczyk PS; Grieco VS; Agoff SN
    Am J Clin Pathol; 2005 Sep; 124(3):355-60. PubMed ID: 16191503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Ancillary Techniques in Biliary Cytopathology Specimens.
    Layfield L
    Acta Cytol; 2020; 64(1-2):175-181. PubMed ID: 31121596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.